Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Infinity Pharmaceuti (INFI)

Infinity Pharmaceuti (INFI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Infinity Pharmaceuti 784 MEMORIAL DRIVE CAMBRIDGE MA 02139 USA

P: 617-453-1000 F: 617-453-1001

Description:

Infinity Pharmaceuticals, Inc. is an innovative cancer drug discovery and development company that is seeking to leverage its strength in small molecule drug technologies to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions.

Key Statistics

Overview:

Market Capitalization, $K 71,857
Shares Outstanding, K 57,029
Annual Sales, $ 22,150 K
Annual Net Income, $ -11,250 K
Last Quarter Sales, $ 340 K
Last Quarter Net Income, $ -11,420 K
60-Month Beta 1.86
% of Insider Shareholders 12.12%
% of Institutional Shareholders 51.46%
Float, K 50,117
% Float 87.88%

Growth:

1-Year Return -2.33%
3-Year Return -1.56%
5-Year Return -92.89%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 92.42%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 10/30/19
Earnings Per Share ttm -0.76
EPS Growth vs. Prev Qtr -11.11%
EPS Growth vs. Prev Year -186.96%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-4 on 09/13/06

INFI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -4.67
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -125.37
Return-on-Assets (Before Tax) -66.89
Profit Margin % -50.79
Net Margin % -59.31
Debt/Equity 0.06
Price/Sales 3.19
Price/Cash Flow N/A
Price/Book 3.80
Book Value/Share 0.33
Interest Coverage -124.00
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar